GDF15 and atrial fibrillation: Patients with high GDF-15 (≥ 1661.0 pg/mL) did not differ from the remaining subjects with regard to the type of AF, comorbidities or medications used except for lower prevalence of diabetes and lower use of torasemide in the former group (Table 1).